Back to search

Article

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration

2021-02-09

Abstract excerpt

The dramatically expanding COVID-19 needs multiple effective countermeasures. Neutralizing antibodies are a potential therapeutic strategy for treating COVID-19. A number of neutralizing nanobodies (Nbs) were reported for their in vitro activities. However, in vivo protection of these nanobodies was not reported in animal models. In the current report, we characterized several RBD-specific Nbs isolated from a sc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9b6d64e6-ea28-589f-9509-d58e8c3bb5f7
DOI
10.1101/2021.02.08.429275
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administrationDOI 10.1101/2021.02.08.429275
Select a neighboring publication to make it the new centre.